DC 7723Hematologic & Lymphatic System38 CFR § 4.117

Acquired hemolytic anemia

The VA rates Acquired hemolytic anemia under Diagnostic Code 7723 across 5 severity levels, from 0% to 100%. At 100%, veterans receive $3939/month or more in compensation.

Rating schedule — DC 7723 at a glance

Minimum rating
0%

Lowest schedular rating available

Maximum rating
100%

Full schedular disability

Rating tiers
5

0%, 10%, 30%, 60%, 100%

CFR section
§ 4.117

Part 4 rating schedule

Body system
Hematologic & Lymphatic System
Secondary conditions
0

None mapped

What are the VA rating criteria for Acquired hemolytic anemia?

RatingCriteria
0%

Asymptomatic

10%

Requiring one course of immunosuppressive therapy per 12-month period

30%

Requiring at least 2 but less than 4 courses of immunosuppressive therapy per 12-month period

60%

Requiring immunosuppressive medication 4 or more times per 12-month period

100%

Requiring a bone marrow transplant or continuous intravenous or immunosuppressive therapy (e.g., prednisone, Cytoxan, azathioprine, or rituximab)

Requiring at least 2 but less than 4 courses of immunosuppressive therapy per 12-month period

Common Questions About Acquired hemolytic anemia VA Ratings

What is the VA rating range for Acquired hemolytic anemia?

The VA rates Acquired hemolytic anemia under Diagnostic Code 7723 at 0%, 10%, 30%, 60%, 100%. The minimum 0% rating requires: Asymptomatic. The maximum 100% rating requires: Requiring a bone marrow transplant or continuous intravenous or immunosuppressive therapy (e.g., prednisone, Cytoxan, azathioprine, or rituximab).

Which 38 CFR diagnostic code does the VA use for Acquired hemolytic anemia?

The VA rates Acquired hemolytic anemia under Diagnostic Code (DC) 7723, governed by 38 CFR 38 CFR § 4.117. The diagnostic code establishes the specific rating tiers and severity criteria the VA examiner applies.

What is the difference between a 0% and a 100% rating for Acquired hemolytic anemia?

A 0% rating requires: Asymptomatic. A 100% rating requires: Requiring a bone marrow transplant or continuous intravenous or immunosuppressive therapy (e.g., prednisone, Cytoxan, azathioprine, or rituximab). The difference typically reflects the frequency, severity, or functional impact of the condition as documented in medical records and C&P examination findings.

Can Acquired hemolytic anemia qualify for TDIU?

Yes — a 100% rating for Acquired hemolytic anemia alone meets the single-disability threshold for TDIU (38 CFR § 4.16). If the condition prevents substantially gainful employment, the veteran is compensated at the 100% rate without a schedular 100% rating.

What evidence supports a higher rating for Acquired hemolytic anemia?

The key evidence for Acquired hemolytic anemia is documentation of how the condition affects daily functioning. Treatment records showing worsening symptoms, functional limitations documented by your provider, and buddy statements describing observable impact on daily life all strengthen the claim. A nexus letter from a qualified medical professional linking the current severity to service is essential for contested claims.

What happens at the C&P exam for Acquired hemolytic anemia?

The C&P examiner uses a Hematologic & Lymphatic System DBQ and evaluates your condition against the DC 7723 rating criteria. The examiner documents symptom frequency, severity, and functional impact. Bring all treatment records and describe your worst days, not your best — the VA rates on the full clinical picture across time, not a snapshot of one good day.

Get a Personalized Rating Analysis

VeteranHQ evaluates your symptoms against the exact 38 CFR criteria, identifies secondary conditions, and shows what evidence you need to support a higher rating.

Discover Your Benefits